NiaShure (Niacin)

NiaShure is a rumen-protected niacin (nicotinic acid) product formulated exclusively for dairy and beef cattle, using encapsulation technology to bypass rumen degradation and deliver niacin to the small intestine. It is not intended or approved for human consumption, and all documented benefits apply solely to bovine animal nutrition and heat stress management.

Origin & History

NiaShure is a branded, rumen-protected form of niacin (nicotinic acid) developed by Balchem for ruminant animal feed, consisting of 65-71% niacin encapsulated with hydrogenated vegetable oil. The proprietary encapsulation process makes it approximately 85% rumen stable, delivering eight times more bioavailable niacin to the small intestine compared to raw niacin in cattle.

Historical & Cultural Context

No evidence of traditional medicinal use exists for NiaShure, as it is a modern branded veterinary product. While niacin itself was discovered in the 20th century for pellagra prevention, NiaShure is exclusively a contemporary animal nutrition ingredient with no roots in historical herbal traditions.

Health Benefits

• No human health benefits documented - NiaShure is exclusively formulated for ruminant (cattle) nutrition, not human consumption
• In cattle: Reduces core body temperature by 1°F during peak heat stress (Collier et al., 2006 - animal study)
• In cattle: Lowers prepartum non-esterified fatty acid (NEFA) surges by limiting lipid mobilization (animal study evidence)
• In cattle: Supports heat shock protein (HSP70) production via increased prostaglandin D (animal study evidence)
• No human clinical trials, RCTs, or meta-analyses exist for this veterinary product

How It Works

NiaShure delivers encapsulated nicotinic acid past the rumen to the small intestine, where it is absorbed and converted to NAD+ (nicotinamide adenine dinucleotide), a coenzyme critical to cellular energy metabolism and fatty acid oxidation. In cattle, nicotinic acid activates the GPR109A receptor on adipocytes, inhibiting hormone-sensitive lipase and thereby reducing lipolysis and the release of non-esterified fatty acids (NEFAs) into the bloodstream. Additionally, niacin-mediated vasodilation via prostaglandin D2 release from dermal Langerhans cells is thought to enhance cutaneous blood flow, facilitating heat dissipation and lowering core body temperature during heat stress.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for NiaShure were identified, as it is formulated exclusively for ruminant nutrition. Available research consists of animal studies in cattle, including work by Collier et al. (2006) on heat stress reduction and studies on milk yield in Holstein cows, though specific design details and PMIDs were not provided in the research dossier.

Clinical Summary

Research on NiaShure is conducted exclusively in animal models, primarily periparturient dairy cows. Collier et al. (2006) demonstrated that rumen-protected niacin supplementation reduced core body temperature by approximately 1°F (0.56°C) during peak heat stress conditions in cattle. Additional bovine studies have shown significant reductions in prepartum non-esterified fatty acid (NEFA) concentrations, suggesting improved hepatic metabolic health around calving. No human clinical trials exist for NiaShure, and its encapsulation matrix is specifically engineered for ruminant gastrointestinal physiology, making extrapolation of efficacy to humans scientifically unsupported.

Nutritional Profile

{"macronutrients": {"protein": "Not applicable for human consumption", "fiber": "Not applicable for human consumption"}, "micronutrients": {"niacin": "Approximately 20% concentration by weight", "bioavailability": "Formulated for ruminant digestion, not bioavailable for humans"}, "bioactive_compounds": {"niacin": "Active compound designed for ruminant use", "bioavailability": "Optimized for ruminant absorption, not suitable for human bioavailability"}}

Preparation & Dosage

NiaShure is provided as a feed premix (65-71% niacin content) for ruminants only, not for human consumption. No clinically studied human dosages exist as this is a veterinary product. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - veterinary product only

Safety & Interactions

NiaShure is not formulated, tested, or approved for human consumption, and no human safety profile exists for this specific encapsulated product. Standard nicotinic acid in humans can cause cutaneous flushing, hepatotoxicity at high doses (>2g/day), gastrointestinal distress, and clinically significant elevations in blood glucose and uric acid. In humans, nicotinic acid interacts with statins (increased myopathy risk), anticoagulants (potentiated bleeding), and antidiabetic medications (reduced glycemic control). Human use of NiaShure should be avoided entirely, and individuals seeking niacin supplementation should use products specifically formulated and tested for human use.